Drug profile · INN
insulin aspart + insulin aspart protamine
NOVOMIX 30 FLEXPEN
insulin aspart + insulin aspart protamine (NOVOMIX 30 FLEXPEN) is an FDA-listed pharmaceutical active ingredient. Associated with NovoThirteen.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — insulin aspart + insulin aspart protamine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
insulin aspart + insulin aspart protamine (NOVOMIX 30 FLEXPEN) is an FDA-listed pharmaceutical active ingredient. Associated with NovoThirteen.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is insulin aspart + insulin aspart protamine?
insulin aspart + insulin aspart protamine (NOVOMIX 30 FLEXPEN) is an FDA-listed pharmaceutical active ingredient. Associated with NovoThirteen.
What is the brand name for insulin aspart + insulin aspart protamine?
NOVOMIX 30 FLEXPEN is a marketed brand name for insulin aspart + insulin aspart protamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.